Physician profile
Daniel P Sneed
NPI 1750309050
$1,606.28
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $735 · 2021: $433 · 2023: $20.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $306.82 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.75 | 2019-2021 | |
| Allergan, INC. | $176.22 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $175.76 | 2020-2021 | |
| Lilly USA, LLC | $152.60 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $118.35 | 2019-2021 | |
| Abbvie INC. | $111.09 | 2021-2023 | Vraylar |
| Janssen Pharmaceuticals, INC | $56.57 | 2019-2021 | |
| Novo Nordisk INC | $42.32 | 2019-2021 | |
| Amgen INC. | $37.92 | 2020 | |
| Adlon Therapeutics L.P. | $36.50 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $34.53 | 2019 | |
| Astellas Pharma US INC | $32.85 | 2020 | |
| Pfizer INC. | $30.19 | 2019 | |
| Si-Bone, INC. | $24.35 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $19.92 | 2021 | |
| Genentech USA, INC. | $16.07 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.35 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.81 | 2021 | |
| Shire North American Group INC | $14.74 | 2019 | |
| Antares Pharma, INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sneed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.